{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:30:58Z","timestamp":1669818658022},"reference-count":3,"publisher":"Academy of Managed Care Pharmacy","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.18553\/jmcp.2019.25.6.630","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:25:12Z","timestamp":1559042712000},"page":"630-634","source":"Crossref","is-referenced-by-count":2,"title":["A Summary from the Institute for Clinical and Economic Review\u2019s New England Comparative Effectiveness Public Advisory Council"],"prefix":"10.18553","volume":"25","author":[{"given":"Ifeoma S.","family":"Otuonye","sequence":"first","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Banken","sequence":"additional","affiliation":[{"name":"Direction de sant\u00e9 publique, CISSS de Laval, Qu\u00e9bec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun M.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9382"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.1052"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:25:30Z","timestamp":1559042730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2019.25.6.630"}},"subtitle":["Effectiveness and Value of Extended-Release Opioid Agonists and Antagonists for Addiction Treatment of Opioid Use Disorder"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.18553\/jmcp.2019.25.6.630"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2019.25.6.630","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}